Compounds > gemcitabine

Page last updated: 2024-08-24

gemcitabine and lomustine

gemcitabine has been researched along with lomustine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	4 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Kitchell, BE; Moore, AS	1
Deray, G; Isnard-Bagnis, C; Janus, N; Karie, S; Launay-Vacher, V	1
Filatova, LV; Gershanovich, ML; Latipova, DKh; Semiglazova, TIu; Stukov, AN; Tarasenkova, AA; Vershinina, SF	1
Filatova, LV; Gershanovich, ML; Latinova, DKh; Semiglazova, TIu; Stukov, AN; Tarasenkova, AA; Vershinina, SF; Zargarova, NI	1

Reviews

2 review(s) available for gemcitabine and lomustine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
New chemotherapy agents in veterinary medicine. The Veterinary clinics of North America. Small animal practice, 2003, Volume: 33, Issue:3 Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Deoxycytidine; Dog Diseases; Dogs; Gemcitabine; Ifosfamide; Lomustine; Mesna; Neoplasms; Streptozocin; Veterinary Drugs	2003

Other Studies

4 other study(ies) available for gemcitabine and lomustine

Article	Year
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations. European journal of medicinal chemistry, 2010, Volume: 45, Issue:4 Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water	2010
[Chemotherapy and renal toxicity]. Bulletin du cancer, 2008, May-28, Volume: 95 FMC Onco Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carboplatin; Carmustine; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Kidney; Kidney Diseases; Lomustine; Methotrexate; Organoplatinum Compounds; Oxaliplatin	2008
[Investigation of gemcitabine plus lomustine treatment in mice with transplantable lymphosarcoma LIO-1]. Voprosy onkologii, 2011, Volume: 57, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Lomustine; Lymphoma, Non-Hodgkin; Maximum Tolerated Dose; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Random Allocation	2011
[Combined effect of gemcitabine and lomustine in mice with intracranial transplanted lymphosarcoma LIO-1]. Voprosy onkologii, 2012, Volume: 58, Issue:3 Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Synergism; Gemcitabine; Injections, Intraperitoneal; Lomustine; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Mice; Survival Analysis	2012